Average Co-Inventor Count = 6.13
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agouron Pharmaceuticals, Inc. (10 from 174 patents)
2. Cidara Therapeutics, Inc. (3 from 15 patents)
3. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
4. Lawrence Livermore National Security, LLC (2 from 1,572 patents)
5. Kalypsys, Inc. (2 from 17 patents)
6. Pfizer Corporation (1 from 4,455 patents)
18 patents:
1. 12427200 - Compositions and methods for the treatment of viral infections
2. 11833213 - Compositions and methods for the treatment of viral infections
3. 11510992 - Compositions and methods for the treatment of viral infections
4. 10865216 - Tricyclic Gyrase inhibitors
5. 10385055 - Tricyclic gyrase inhibitors
6. 8569300 - Substituted tetrazolo[1,5-A]pyrazine inhibitors of histamine receptors for the treatment of disease
7. 8080566 - Carbazole inhibitors of histamine receptors for the treatment of disease
8. 7473790 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
9. 7148226 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
10. 7141587 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11. 7115658 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase
12. 7053107 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
13. 6891044 - Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
14. 6884890 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
15. 6878727 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same